2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
9
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Barrett Esophagus
3
Stomach Neoplasms
2
Recurrence
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Multiple Pulmonary Nodules
2
Melanoma
2
Glioma
2
Colorectal Neoplasms
2
Adenocarcinoma of Lung
2
Triple Negative Breast Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Spinal Fractures
1
Solitary Pulmonary Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Phyllodes Tumor
1
Osteoporosis
1
Nevus
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Lymphoma, Follicular
1
Lung Diseases
1
Interventions
Doxorubicin
17
Echocardiography
14
Exercise
9
Cyclophosphamide
9
Trastuzumab
8
Dexrazoxane
8
Electrocardiography
7
Razoxane
6
Carvedilol
6
Vincristine
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Cisplatin
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Social Determinants of Health
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Leucovorin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Diagnostic Imaging
×
Clear all
NCT06986291
2025-05-29
CorTox
Technische Universität Dresden
Phase NA
Not yet recruiting
325 enrolled